SCHEMBL1239

SCHEMBL1239

Cc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1N(C)CCCc1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC3 O15438 1/20 0.42
ABCC4 O15439 1/20 0.42
ABCB11 O95342 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2C9 P11712 1/20 0.42
ABCB4 P21439 1/20 0.42
LPAR1 Q92633 1/20 0.42
ABCC2 Q92887 1/20 0.42
SLCO1B3 Q9NPD5 1/20 0.42
SLCO1B1 Q9Y6L6 1/20 0.42
MCHR1 Q99705 2/20 0.38
CHRM1 P11229 2/20 0.38
HTR2A P28223 1/20 0.38
MAP4K4 O95819 2/20 0.36
HSD11B1 P28845 3/20 0.36
AVPR1A P37288 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
ALOX5 P09917 1/20 0.34
ALOX5AP P20292 1/20 0.34
ALDH1A1 P00352 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL982 0.92 LPAR1 (0.48) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL1323 0.90 OPRM1 (0.44) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL1630 0.90 ABCC3 (0.42) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL1127 0.89 LPAR1 (0.43) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL7148 0.88 ALDH1A1 (0.38) LPAR1MCHR1CHRM1HTR2AFFAR4
SCHEMBL2214 0.86 LPAR1 (0.45) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL7415 0.85 LPAR1 (0.46) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL2292 0.84 CYP2C9 (0.42) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL7666 0.84 ABCC3 (0.44) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL6445 0.84 CHRM1 (0.36) MCHR1CHRM1HTR2AFFAR4ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP claimed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO claimed
EP-2483253-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed
WO-2011041729-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed